Hand ischaemia risk after creating an arteriovenous fistula

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, non-interventional, single-centre descriptive study enrolling adult patients with stage 5 chronic kidney disease who are scheduled for an arteriovenous fistula at Hôpital Privé des Peupliers. Routine clinical and vascular function data will be collected before surgery and at 1, 6, and 12 months after the procedure to identify functional vascular changes and clinical factors linked to short- and medium-term hand ischaemia. No experimental treatment, randomisation, or comparator is used and all care follows standard practice. The aim is to characterise the frequency, timing, and predictors of access-related hand ischaemia to inform future risk stratification and management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years;
* Stage 5 chronic kidney disease, on dialysis or not on dialysis;
* Requiring the creation of an arteriovenous fistula;
* Membership of a social insurance scheme;
* Patient having been informed and having formulated his/her oral non-opposition to participate in the research.

Exclusion Criteria:

* Contraindication to the proposed surgery ;
* Reduced life expectancy in the opinion of the investigator;
* Medical or biological conditions which, in the opinion of the investigator, could influence the interpretation of the results of the study or the safety of the patient;
* Patient uncooperative with protocol requirements or unable to attend scheduled visits to the centre;
* Other surgical or medical intervention planned during the study;
* Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
* Participating in another clinical trial, or in a period of exclusion from another clinical trial;
* Patient under guardianship or deprived of liberty.

Where it's running

• Hôpital Privé des Peupliers
  Paris, France Recruiting

Study contacts

• Study coordinator: Viviane DUEDAL, MD
• Email: v.duedal@gmail.com
• Phone: 6 70 80 18 98

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Post-filter hematocrit calculation for adults on continuous renal replacement therapy

  This will test whether a calculation can accurately predict post-filter hematocrit compared with machine-measured values in adults receiving continuous renal replacement therapy.

  Recruiting University of Iowa · Iowa City, Iowa · NCT07293936

• Preventing kidney injury after heart surgery

  This study is testing if Coenzyme Q10 and Glutathione can help prevent kidney injury in patients having heart surgery.

  Recruiting Phase 2 George Washington University · Washington D.C., District of Columbia · NCT06620523

• Pediatric use of multiFiltratePRO for CVVHD in kids

  This study tests whether the paediatric mode of multiFiltratePRO can deliver at least 80% of the prescribed CVVHD dose within 72 hours in children with acute kidney injury.

  Recruiting at 2 sites Fresenius Medical Care Deutschland GmbH · Ostrava-Poruba and 1 other locations · NCT06603324

• Induction treatment for newly diagnosed multiple myeloma patients with renal failure

  This study is testing a new treatment plan for people with newly diagnosed multiple myeloma and kidney problems to see if it helps them respond better to therapy.

  Recruiting Early Phase 1 Augusta University · Augusta, Georgia · NCT06142396

• Using SGLT2 inhibitors with lifestyle changes to prevent complications in prediabetes patients

  This study is testing if a diabetes medication combined with lifestyle changes can help people with prediabetes and early kidney problems avoid serious health issues.

  Recruiting at 9 sites Phase 4 University Hospital Tuebingen · Berlin and 8 other locations · NCT06054035

• SelfWrap-Assisted Arteriovenous Fistulas for Chronic Kidney Disease

  This study is testing if a new wrap called SelfWrap can make it safer and more effective for people with chronic kidney disease to have a new arteriovenous fistula created.

  Recruiting at 28 sites VenoStent · Bullhead City, Arizona and 27 other locations · NCT06001827

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.